Clinical Trial Update: Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD). [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and potential efficacy of IVB103 injection in adults with neovascular age-related macular degeneration; enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• IVB103

Snippet

Sponsor: InnoVec Biotherapeutics Inc. | Conditions: nAMD | Phase 1 | Status: ENROLLING_BY_INVITATION